Journals / Dicle Tıp Dergisi / 2010 / Cilt: 37 - Sayı: 1

Hipertiroid hastalarda tedavi öncesi ve sonrası lipid profli ile homosistein, leptin, fbrinojen ve C-reaktif protein düzeyleri

Lipid profle and levels of homocysteine, leptin, fbrinogen and C-reactive protein in hyperthyroid patients before and after treatment

Pages
1–7
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These changes may refect low-gradeinfammation or disturbances in coagulation in hyperthyroidism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The present study was carried out to determine whether thyroid hormones affect lipid profle and levels of erithrocyte sedimentation rate (ESR), serum total homocysteine (t-hcy), leptin, fbrinogen, C-reactive protein (CRP in patients with hyperthyroidism.
📊
Key Findings & Data:Materials and methods: This study was carried out on 23 hyperthroid subjects (3 men / 20 women, mean age 41.8 ± 2.4 years).
💡
Conclusion & Impact:These changes may refect low-gradeinfammation or disturbances in coagulation in hyperthyroidism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The present study was carried out to determine whether thyroid hormones affect lipid profle and levels of erithrocyte sedimentation rate (ESR), serum total homocysteine (t-hcy), leptin, fbrinogen, C-reactive protein (CRP in patients with hyperthyroidism. Materials and methods: This study was carried out on 23 hyperthroid subjects (3 men / 20 women, mean age 41.8 ± 2.4 years). Serum levels of homocysteine, leptin, fbrinogen, CRP, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and ESR were measured and body mass index (BMI) were calculated before and after treatment of hyperthyroidism. Results: Pretreatment t-hcy, TC, LDL-C, HDL-C levels and BMI of patients were signifcantly lower than those of the post-treatment (p<0.001, for each variable). However, fbrinogen and ESR decreased after the treatment (p<0.001 and p<0.05, respectively). There were no differences in leptin and CRP levels between pre- and posttreatment periods. Pre and post treatment TC and LDL-C levels were negatively correlated with free triiodothyronine (fT3) levels (r=-0.588, p<0.01; r=-0.534, p<0.01; r=-0.543, p<0.01 and r =-0.653, p<0.01, respectively). Pre-treatment HDL-C was inversely correlated with TSH (r=-0.423, p<0.05). Pre-post- treatment LDL-C was negatively correlated with free thyroxine (fT4) levels (r=-0.536, p<0.001 and r=- 0.422, p<0.05 respectively). Pre-treatment TC was inversely correlated with fT4 (r=-0.590, p<0.01). Conclusion: Hyperthyroidism is associated with high plasma fbrinogen and ESR levels. Elevated plasma fbrinogen and ESR levels may be a possible explanation for the high cardiovascular morbidity among hyperthyroidic subjects. These changes may refect low-gradeinfammation or disturbances in coagulation in hyperthyroidism.

Özet

Amaç: Bu çalışma hipertiroidizmli hastalarda tiroid hormonlarının lipid proflini, eritrosit sedimentasyon hızını (ESR), serum total homosistein (t-hcy), leptin, fbrinojen ve C-reaktif protein (CRP) düzeylerini etkileyip etkilemediğini tespit etmek için tasarlanmıştır. Gereç ve yöntem: Bu çalışma yaş ortalaması 41.8±2.4 yıl arasında olan 23 hipertiroid (3 erkek/ 20 kadın) ile gerçekleştirildi. Homosistein, leptin, fbrinojen, CRP, total kolesterol (TK), yüksek dansiteli lipoprotein kolesterol (HDL-K), düşük dansiteli lipoprotein kolestrol (LDL-K)’ün serum düzeyleri ve ESR ölçüldü ve vücut kütle indeksi (BMI) tedaviden önce ve sonra hesaplandı. Bulgular: Hipertiroid hastalarının tedavi öncesi t-hcy, TC, LDL-Kolesterol, HDL-Kolesterol düzeyleri ve BMI tedavi sonrası düzeylerden daha düşüktü (tüm değişkenler için, p 0.05). Tedavi öncesi ve sonrası TC ve LDL-K serbest triiodotironin (fT3) düzeyleri ile negatif olarak korele idi (sırasıyla, r=-0.588, p<0.01; r=-0.534, p<0.01; r=-0.543, p<0.01 ve r=-0.653, p<0.01). Tedavi öncesi HDL-K TSH ile tersine uyumluydu (r=-0.423, p<0.05). Tedavi öncesi ve sonrası LDL-K serbest tiroksin (fT4) düzeyleri ile negatif uyumluydu (sırasıyla, r=-0.536, p<0.001 ve r=-0.422, p<0.05). Tedavi öncesi TC seviyeleri ile fT4 arasında tersine bir uyum vardı (r=-0.590, p<0.01). Sonuç: Hipertiroid durumu, yüksek plazma fbrinojen ve ESR düzeyleri ile ilişkilidir. Yükselmiş plazma fbrinojen ve ESR düzeyleri bu durumdan etkilenmiş kişiler arasında yüksek kardiovasküler morbidite için açıklanabilen muhtemel bir durum olabilir. Bu değişimler düşük seviye infamasyonu ya da hipertitoidizmdeki dağılımı yansıtabilir.

🔖

Cite This Article

SÜTKEN, E., AKALIN, A., ÖZDEMİR, F., ÇOLAK, Ö. (2010). Hipertiroid hastalarda tedavi öncesi ve sonrası lipid profli ile homosistein, leptin, fbrinojen ve C-reaktif protein düzeyleri. Dicle Tıp Dergisi, Cilt: 37 - Sayı: 1, 1–7. https://ajindex.com/articles/349180

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Faber J, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 2001;145:391-396
  2. Diekman MJ, Anghelescu N, Endert E, Bakker O, Wiersinga WM. Changes in plasma low-density lipoprotein (LDL) - and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. J Clin Endocrinol Metab 2000;85:1857-1862
  3. Wonn-Young L, Jung-Yul S, Eun-Jung R, Jeong-Sik P, KiChul S, Sun-Woo K. Plasma CRP, Apolipoprotein A-1, Apolipoprotein B and Lp (a) levels according to thyroid function status. Arch Med Res 2004;35:540-545
  4. Chadarevian R, Bruckert E, Giral P, Turpin G. Relationship between thyroid hormones and fbrinogen levels. Blood Coagul Fibrinolysis 1999;10:481-486
  5. Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM. Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol (Oxf) 2001;54:197-204
  6. Matsubara M, Yoshizawa T, Morioka T, Katayose S. Serum leptin and lipids in patients with thyroid dysfunction. J Atheroscler Thromb 2000;7:50-54
  7. Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997;136:1-7
  8. Yarnell JW, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-844
  9. Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, TegerNilsson AC, Wedel H. Social infuences and cardiovascular risk factors as determinants of plasma fbrinogen concentration in a general population sample of middle aged men. BMJ 1990;10300(6725): 634-638
  10. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fbrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91:191-205
  11. Takeda I, Kometani T. Emergency laboratory service in Shimane Prefectural Central Hospital (author’s transl) Rinsho Byori 1981;29:37-41
  12. Thompson SG, Fechtrup C, Squire E, et al. Antithrombin III and fbrinogen as predictors of cardiac events in patients with angina pectoris. Arterioscler Thromb Vasc Biol 1996;16:357-362
  13. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Evaluation of C-reactive protein, an infammatory marker, and infectious serology a